Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
about
In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression Using the HaloTag Enzyme.Poly(ADP-ribose) polymerase inhibitors combined with external beam and radioimmunotherapy to treat aggressive lymphoma.A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growthRadioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'.Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma.
P2860
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
@ast
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
@en
type
label
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
@ast
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
@en
prefLabel
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
@ast
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
@en
P2093
P2860
P356
P1433
P1476
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
@en
P2093
David M Goldenberg
Habibe Karacay
Robert M Sharkey
P2860
P304
P356
10.1002/CNCR.24802
P407
P433
P577
2010-02-01T00:00:00Z